Drugs / Allogeneic peripheral blood stem cell
Allogeneic peripheral blood stem cell
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03910452 | Oct 2019 → Jun 2034 expected | chronic granulomatous disease | National Institute of Allergy and Infectious Diseases (NIAID) | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogeneic peripheral blood stem cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03910452 ↗ |
| Modality | Cell therapy | “IV infused donor peripheral blood stem cell” NCT03910452 ↗ |
| Route | Intravenous | “IV infused donor peripheral blood stem cell” NCT03910452 ↗ |